(1 - 11 von 14
)
Biotech Networking Event with Swiss Technology Transfer ...Basel Area Business & Innovation
baselarea.swiss
Alexander Gutmans, Walder Wyss Ltd. Daniel Pinschewer, Hookipa & University of Basel Alessandro Mazzetti, Innovation Office University of Basel Lambert Potin, ... Alexander Gutmans, Walder Wyss Ltd. Daniel Pinschewer, Hookipa & University of Basel Alessandro Mazzetti, Innovation Office University of Basel Lambert Potin, ...
Biotech Startup Mekonos raises oversubscribed $25 million ...biotechnology.report
biotechnology.report
— Lambert Potin, Partnering Associate, Search and Evaluation, Debiopharm. Mekonos will use the new capital to expand its MEMS, Microfluidics — Lambert Potin, Partnering Associate, Search and Evaluation, Debiopharm. Mekonos will use the new capital to expand its MEMS, Microfluidics ...
Swiss HLG : “Ready to transact?”Startupticker
www.startupticker.ch
Lambert Potin | Debiopharm; Sébastien Chenuet | Ichnos Pharma; Veronica Gambillara Fonck | Pureos Bioventures. Programme and registration. Event registration ... Lambert Potin | Debiopharm; Sébastien Chenuet | Ichnos Pharma; Veronica Gambillara Fonck | Pureos Bioventures. Programme and registration. Event registration ...
monthly Grad Student Mini-Symposium (IBI-EDBB)Memento EPFL
memento.epfl.ch
Lambert Potin (Swartz Lab) -- Antigen Presentation via MHC Class II by Lymphatic Endothelial Cells Dampens CD4+ T Cell Response Yoji Tabata (Lutolf Lab) ... Lambert Potin (Swartz Lab) -- Antigen Presentation via MHC Class II by Lymphatic Endothelial Cells Dampens CD4+ T Cell Response Yoji Tabata (Lutolf Lab) ...
Innovative drug delivery improves effectiveness of cancer ...Medical Xpress
medicalxpress.com
— ... Lambert Potin, Michal M. Raczy, and Koichi Sasaki; visiting scientists Kazuto Fukunaga and Kiyomitsu Katsumata; and Mariko Yasui, Hiroyuki — ... Lambert Potin, Michal M. Raczy, and Koichi Sasaki; visiting scientists Kazuto Fukunaga and Kiyomitsu Katsumata; and Mariko Yasui, Hiroyuki ...
Novel approach could limit common complicatioEurekAlert!
www.eurekalert.org
— Additional authors were Jun Ishihara, Kazuto Fukunaga, Ako Isihara, Lambert Potin, Peyman Hosseinchi and Melody Swartz from the University — Additional authors were Jun Ishihara, Kazuto Fukunaga, Ako Isihara, Lambert Potin, Peyman Hosseinchi and Melody Swartz from the University ...
Turning cold tumors hot: Drug delivery systemEurekAlert!
www.eurekalert.org
— ... Lambert Potin, Tiffany M. Marchell, Aaron T. Alpar, Michal M. Raczy and Laura T. Gray; and postdoctoral scientists Ako Ishihara and John — ... Lambert Potin, Tiffany M. Marchell, Aaron T. Alpar, Michal M. Raczy and Laura T. Gray; and postdoctoral scientists Ako Ishihara and John ...
Vessels that help cancers spread can also boost ...EPFL
actu.epfl.ch
— Fonds Pierre-François Vittone. Reference. Manuel Fankhauser, Maria A.S. Broggi, Lambert Potin, Natacha Bordry, Laura Jeanbart, Amanda W. Lund — Fonds Pierre-François Vittone. Reference. Manuel Fankhauser, Maria A.S. Broggi, Lambert Potin, Natacha Bordry, Laura Jeanbart, Amanda W. Lund ...
Double agents: Vessels that help cancers spre | EurekAlert!
www.eurekalert.org
· Manuel Fankhauser, Maria A.S. Broggi, Lambert Potin, Natacha Bordry, Laura Jeanbart, Amanda W. Lund, Elodie Da Costa, Sylvie Hauert, ...
Novel Approach Could Limit Common Complications of Immunotherapy
www.newswise.com
Connecting cancer immunotherapy drugs such as anti-CTLA4 and anti-PD-L1 to peptides that bind to tissues in and around tumors enhanced their effects while limit
sortiert nach Relevanz / Datum